Univec, Inc. (UNVC)
OTCMKTS · Delayed Price · Currency is USD
0.0034
-0.0001 (-2.86%)
Oct 27, 2025, 3:41 PM EDT
Univec Market Cap
Univec has a market cap or net worth of $8.83 million as of October 27, 2025. Its market cap has decreased by -35.19% in one year.
Market Cap
8.83M
Enterprise Value
n/a
Revenue
28.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 24, 1997, Univec's market cap has decreased from 23.75M to 8.83M, a decrease of -62.83%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 8.83M | 66.67% |
| Dec 31, 2024 | 5.30M | -46.43% |
| Dec 29, 2023 | 9.89M | -51.00% |
| Dec 30, 2022 | 20.18M | -77.91% |
| Dec 31, 2021 | 91.37M | 345.55% |
| Dec 31, 2020 | 20.51M | 51.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |